磁盘1
精神分裂症(面向对象编程)
神经科学
疾病
神经调节蛋白1
心理学
大脑发育
ERBB4公司
神经发育障碍
机制(生物学)
神经调节蛋白
医学
精神科
生物
基因
受体
内科学
遗传学
哲学
认识论
自闭症
受体酪氨酸激酶
作者
Hanna Jaaro-Peled,Akiko Hayashi‐Takagi,Saurav Seshadri,Atsushi Kamiya,Nicholas J. Brandon,Akira Sawa
标识
DOI:10.1016/j.tins.2009.05.007
摘要
Schizophrenia (SZ) is primarily an adult psychiatric disorder in which disturbances caused by susceptibility genes and environmental insults during early neurodevelopment initiate neurophysiological changes over a long time course, culminating in the onset of full-blown disease nearly two decades later. Aberrant postnatal brain maturation is an essential mechanism underlying the disease. Currently, symptoms of SZ are treated with anti-psychotic medications that have variable efficacy and severe side effects. There has been much interest in the prodromal phase and the possibility of preventing SZ by interfering with the aberrant postnatal brain maturation associated with this disorder. Thus, it is crucial to understand the mechanisms that underlie the long-term progression to full disease manifestation to identify the best targets and approaches towards this goal. We believe that studies of certain SZ genetic susceptibility factors with neurodevelopmental implications will be key tools in this task. Accumulating evidence suggests that neuregulin-1 (NRG1) and disrupted-in-schizophrenia-1 (DISC1) are probably functionally convergent and play key roles in brain development. We provide an update on the role of these emerging concepts in understanding the complex time course of SZ from early neurodevelopmental disturbances to later onset and suggest ways of testing these in the future.
科研通智能强力驱动
Strongly Powered by AbleSci AI